Renoquid

Active Ingredient(s): Sulfacytine
FDA Approved: * September 12, 1975
Pharm Company: * GLENWOOD
Category: Antibiotics

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Renoquid Overview

Sulfacytine is a short-acting sulfonamide antibiotic, taken orally for treatment against bacterial infections. Sulfonamides, as a group of antibiotics, work by inhibiting the bacterial synthesis of folate.[1] In 2006 the drug was discontinued[2][3] References ^ DrugBank DB01298 ^ Federal Register Section: Food and Drug Administration [Docket No. 2006N–0222] Merck & Co., Inc., et al.; Withdrawal of Approval of 65 New Drug Appli...

Read more Renoquid Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Sulfacytine

Recent Renoquid Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Sulfacytine
  • Tablet: 250mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Sulfacytine or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 14 October 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA